Next Super Hyper Growth Stock? Numinus Wellness (TSXV: NUMI) (OTC: LKYSF)
Channel: RICH TV LIVE
Date: 03/03/2021

Next Super Hyper Growth Stock? Numinus Wellness (TSXV: NUMI) (OTC: LYKSF) (TSXV: NUMI) (OTC: LYKSF) - RICH TV LIVE - March 3, 2021 -  Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that effective January 4, 2021, it entered into a lab services agreement with Numinus Wellness Inc. ("Numinus"). Recognized as an early leader in developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies (PAP), Numinus is aiding Optimi’s mission to further the research and development of Canadian-grown psilocybin-producing mushrooms and related product formulations.

Through this foundational agreement, Optimi will utilize and leverage the services of Numinus and its laboratories, equipment, services, expertise, and specialized focus with the goal of developing products for the emerging psychedelic industry. Optimi applied for and has received a research exemption from Health Canada allowing it to conduct research activities involving psychedelic compounds, specifically psilocybin and psilocin. Optimi has further applied for and is awaiting approval of a dealer’s license necessary to undertake certain additional aspects of its research and development. The Company has elected to move ahead by undertaking several research and development projects with Numinus specifically related to Psilocybe mushrooms, psychedelic compounds, and formulations within their licensed facilities. All resulting intellectual property (IP) will be 100% owned by Optimi.

"While we finalize our facility construction, build-out, and dealers licensing approval, Numinus offered an ideal partnership to further our research and development of Psilocybe mushroom and associated derivatives-based products," said JJ Wilson, Chairman of the Board, Optimi. “Numinus’ operational state-of-the art laboratory, specialized equipment and significant expertise in psychedelic research will be critical to rapidly advancing the development of safe, effective, and all-natural formulations within the strategic criteria and timelines necessary to create what we envision as future sector leading made-in-Canada, pharmaceutical-grade psilocybin mushroom products.”

As set out in previous news releases, Optimi is pleased to further advise that upon the conclusion of its over $20M oversubscribed initial public offering and commencement of trading on the Canadian Securities Exchange (CSE, ticker OPTI), that strategic activities for 2021 are expected to move ahead rapidly. Noteworthy items include continued construction and build-out of its dual facility (combined 20,000 sq. ft.) operations in Princeton, British Columbia. Upon completion, integrated cultivation, advanced agronomy, genomic research, processing, manufacturing, and laboratory services will be housed on the property which includes additional space for expansion. In addition, several strategic relationships and manufacturing arrangements are advancing; we expect further details to be available shortly.

#numiuswellness #psychedelics #richtvlive 

JOIN RICH TV LIVE TRADING CLUB HERE -  http://www.richpicksdaily.com 

Subscribe - https://www.youtube.com/c/RICHTVLIVE
Visit - http://www.richtvlive.com/ & www.richpicksdaily.com a community for stocks, news, and trending topics. #richtvlive #richpicksdaily #stocks 

Disclaimer

RICH TV LIVE INC. company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RICH TV LIVE reports company profiles or other investor relations materials and presentations are subject to change. RICH TV LIVE and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time. RICH TV LIVE INC. sponsored $1,500 CAD for digital video services. 

Investing is inherently risky. RICH TV LIVE is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print. 

We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov/Canadian CSA https://www.securities-administrators.ca/.